Hazards of prothrombin-complex concentrates in treatment of hemophilia

Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy. The KOGENATE Study Group.

Haemophilia : the official journal of the World Federation of Hemophilia·1999

Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.

Thrombosis and haemostasis·1996

Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group.

Blood·1994

Medical management of extensive spinal epidural hematoma in a child with factor IX deficiency.

Pediatric emergency care·1994

Alpha 2-antiplasmin deficiency. An overlooked cause of hemorrhage.

The American journal of pediatric hematology/oncology·1993

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group.

The New England journal of medicine·1993

Advances in Systemic Treatment of Breast Cancer.

The New England journal of medicine·2026

Optogenetic Therapy for Restoring Aspects of Visual Function.

The New England journal of medicine·2026

Longitudinal plasma proteome profiling after allogeneic hematopoietic stem cell transplantation: heterogeneous development and associations with acute GvHD.

Frontiers in immunology·2026

Soluble Indicators of Endothelial Injury and Activation Emerge During Acute HIV Infection and Persist Despite Rapid Antiretroviral Therapy Initiation.

The Journal of infectious diseases·2026

Evaluation of Different Methods of Haemoglobin Estimation Among Malaria-Infected Patients.

Journal of clinical laboratory analysis·2026

100 Years of von Willebrand Disease (VWD): Comparison of Historical and Contemporary von Willebrand Factor (VWF) Activity Assays in the Laboratory Identification of VWD.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

A Novel Indicator of Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation: Current CMV Reactivation.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Acute Ischaemic Stroke: Therapeutic Targets and Key Modulators of the Fibrinolytic System and Clot Formation.

Translational stroke research·2026

Related Experiment Videos

Hazards of prothrombin-complex concentrates in treatment of hemophilia

Related Concept Videos

Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy. The KOGENATE Study Group.

Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.

Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group.

Medical management of extensive spinal epidural hematoma in a child with factor IX deficiency.

Alpha 2-antiplasmin deficiency. An overlooked cause of hemorrhage.

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group.

Advances in Systemic Treatment of Breast Cancer.

Optogenetic Therapy for Restoring Aspects of Visual Function.

Longitudinal plasma proteome profiling after allogeneic hematopoietic stem cell transplantation: heterogeneous development and associations with acute GvHD.

Soluble Indicators of Endothelial Injury and Activation Emerge During Acute HIV Infection and Persist Despite Rapid Antiretroviral Therapy Initiation.

Evaluation of Different Methods of Haemoglobin Estimation Among Malaria-Infected Patients.

100 Years of von Willebrand Disease (VWD): Comparison of Historical and Contemporary von Willebrand Factor (VWF) Activity Assays in the Laboratory Identification of VWD.

A Novel Indicator of Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation: Current CMV Reactivation.

Acute Ischaemic Stroke: Therapeutic Targets and Key Modulators of the Fibrinolytic System and Clot Formation.

Related Experiment Videos

Hazards of prothrombin-complex concentrates in treatment of hemophilia

Related Concept Videos

Related Articles